Daily serum piperacillin monitoring is advisable in critically ill patients
- Author
- BLONDIAUX, Nicolas1 ; WALLET, Frédéric1 ; FAVORY, Raphaël2 ; ONIMUS, Thierry2 ; NSEIR, Saad2 ; COURCOL, René J1 ; DUROCHER, Alain2 ; ROUSSEL-DELVALLEZ, Micheline1
[1] Pôle de Microbiologie, Centre de Biologie-Pathologie, Centre Hospitalier Régional Universitaire (CHRU) de Lille, Boulevard du Pr. J. Leclercq, 59037 Lille, France
[2] Service de Réanimation Médicale, Hôpital A. Calmette, Centre Hospitalier Régional Universitaire (CHRU) de Lille, Boulevard du Pr. J. Leclercq, 59037 Lille, France - Source
International journal of antimicrobial agents (Print). 2010, Vol 35, Num 5, pp 500-503, 4 p ; ref : 15 ref
- ISSN
- 0924-8579
- Scientific domain
- Microbiology, infectious diseases; Pharmacology drugs
- Publisher
- Elsevier, Amsterdam
- Publication country
- Netherlands
- Document type
- Article
- Language
- English
- Author keyword
- Appropriate antibiotic administration Daily serum concentration monitoring Intensive Care Unit Piperacillin
- Keyword (fr)
- Antibactérien Antibiotique Concentration Homme Liquide biologique Malade état grave Monitorage Pipéracilline Surveillance Sérum Unité soin intensif Dérivé de la pénicilline β-Lactamines
- Keyword (en)
- Antibacterial agent Antibiotic Concentration Human Biological fluid Critically ill Monitoring Piperacillin Surveillance Serum Intensive care unit Penicillin derivatives β-Lactams
- Keyword (es)
- Antibacteriano Antibiótico Concentración Hombre Líquido biológico Enfermo estado grave Monitoreo Piperacilina Vigilancia Suero Unidad terapia intensiva Penicilinas β-Lactams
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22582019
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ijantimicag.2010.01.018 
https://dx.doi.org/10.1016/j.ijantimicag.2010.01.018
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1016\/j.ijantimicag.2010.01.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:9:\"\u0000*\u0000jtitle\";s:53:\"International journal of antimicrobial agents (Print)\";s:9:\"\u0000*\u0000stitle\";s:34:\"Int. j. antimicrob. agents (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"500\";s:8:\"\u0000*\u0000epage\";s:3:\"503\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0924-8579\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"BLONDIAUX\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Nicolas\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"WALLET, Fr\u00e9d\u00e9ric\";i:1;s:16:\"FAVORY, Rapha\u00ebl\";i:2;s:15:\"ONIMUS, Thierry\";i:3;s:11:\"NSEIR, Saad\";i:4;s:16:\"COURCOL, Ren\u00e9 J\";i:5;s:15:\"DUROCHER, Alain\";i:6;s:28:\"ROUSSEL-DELVALLEZ, Micheline\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1016\/j.ijantimicag.2010.01.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:9:\"\u0000*\u0000jtitle\";s:53:\"International journal of antimicrobial agents (Print)\";s:9:\"\u0000*\u0000stitle\";s:34:\"Int. j. antimicrob. agents (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"500\";s:8:\"\u0000*\u0000epage\";s:3:\"503\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0924-8579\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"BLONDIAUX\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Nicolas\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"WALLET, Fr\u00e9d\u00e9ric\";i:1;s:16:\"FAVORY, Rapha\u00ebl\";i:2;s:15:\"ONIMUS, Thierry\";i:3;s:11:\"NSEIR, Saad\";i:4;s:16:\"COURCOL, Ren\u00e9 J\";i:5;s:15:\"DUROCHER, Alain\";i:6;s:28:\"ROUSSEL-DELVALLEZ, Micheline\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:33:\"10.1016\/j.ijantimicag.2010.01.018\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1016\/j.ijantimicag.2010.01.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:9:\"\u0000*\u0000jtitle\";s:53:\"International journal of antimicrobial agents (Print)\";s:9:\"\u0000*\u0000stitle\";s:34:\"Int. j. antimicrob. agents (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"500\";s:8:\"\u0000*\u0000epage\";s:3:\"503\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0924-8579\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"BLONDIAUX\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Nicolas\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"WALLET, Fr\u00e9d\u00e9ric\";i:1;s:16:\"FAVORY, Rapha\u00ebl\";i:2;s:15:\"ONIMUS, Thierry\";i:3;s:11:\"NSEIR, Saad\";i:4;s:16:\"COURCOL, Ren\u00e9 J\";i:5;s:15:\"DUROCHER, Alain\";i:6;s:28:\"ROUSSEL-DELVALLEZ, Micheline\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1016\/j.ijantimicag.2010.01.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:9:\"\u0000*\u0000jtitle\";s:53:\"International journal of antimicrobial agents (Print)\";s:9:\"\u0000*\u0000stitle\";s:34:\"Int. j. antimicrob. agents (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"500\";s:8:\"\u0000*\u0000epage\";s:3:\"503\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0924-8579\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"BLONDIAUX\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Nicolas\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"WALLET, Fr\u00e9d\u00e9ric\";i:1;s:16:\"FAVORY, Rapha\u00ebl\";i:2;s:15:\"ONIMUS, Thierry\";i:3;s:11:\"NSEIR, Saad\";i:4;s:16:\"COURCOL, Ren\u00e9 J\";i:5;s:15:\"DUROCHER, Alain\";i:6;s:28:\"ROUSSEL-DELVALLEZ, Micheline\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1016\/j.ijantimicag.2010.01.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:9:\"\u0000*\u0000jtitle\";s:53:\"International journal of antimicrobial agents (Print)\";s:9:\"\u0000*\u0000stitle\";s:34:\"Int. j. antimicrob. agents (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"35\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"500\";s:8:\"\u0000*\u0000epage\";s:3:\"503\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0924-8579\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"BLONDIAUX\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Nicolas\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:18:\"WALLET, Fr\u00e9d\u00e9ric\";i:1;s:16:\"FAVORY, Rapha\u00ebl\";i:2;s:15:\"ONIMUS, Thierry\";i:3;s:11:\"NSEIR, Saad\";i:4;s:16:\"COURCOL, Ren\u00e9 J\";i:5;s:15:\"DUROCHER, Alain\";i:6;s:28:\"ROUSSEL-DELVALLEZ, Micheline\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:75:\"Daily serum piperacillin monitoring is advisable in critically ill patients\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
